CLINICAL_TRIALS
trial_result
· 2025-12-04
Clinical Trial Update: A Study of Eptinezumab in Participants With Migraine and Medication Overuse Headache [Phase 4]
Summary
Phase 4 trial of Eptinezumab in participants with migraine and medication overuse headache has completed and results have been posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: H. Lundbeck A/S | Conditions: Migraine, Medication Overuse Headache | Phase 4 | Status: COMPLETED | Results posted: 2025-12-04